Interestingly, UBE2T plays an essential part in the DNA damage pathway, and it has been demonstrated to be correlated intimately with the development and poor prognosis of several cancers, such as gastric cancer, hepatocellular cancer, prostate cancer, and gallbladder cancer (37–40). This evidence concerns the gene UBE2T and hepatocellular carcinoma.